Scarica l'app Stockscreener
15.21
0.98%
-0.155
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DNLI Giù?
Forum
Previsione
Precedente Chiudi:
$15.37
Aprire:
$15.42
Volume 24 ore:
386.21K
Relative Volume:
0.20
Capitalizzazione di mercato:
$2.22B
Reddito:
$340.81M
Utile/perdita netta:
$-419.65M
Rapporto P/E:
-5.3386
EPS:
-2.85
Flusso di cassa netto:
$-402.10M
1 W Prestazione:
-0.00%
1M Prestazione:
+7.25%
6M Prestazione:
+19.84%
1 anno Prestazione:
-45.65%
Intervallo 1D:
$15.07
$15.62
Intervallo di 1 settimana:
$14.85
$16.51
Portata 52W:
$10.57
$33.33
Denali Therapeutics Inc Stock (DNLI) Company Profile
Nome
Denali Therapeutics Inc
Settore
Industria
Telefono
(650) 866-8547
Indirizzo
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
Confronta DNLI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
15.21 | 2.25B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.20 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.85 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.46 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-03-07 | Ripresa | Morgan Stanley | Overweight |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2025-01-07 | Iniziato | Robert W. Baird | Outperform |
| 2025-01-03 | Iniziato | William Blair | Outperform |
| 2024-12-16 | Aggiornamento | Stifel | Hold → Buy |
| 2024-10-10 | Ripresa | Raymond James | Mkt Perform |
| 2024-10-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | Iniziato | Citigroup | Buy |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-09-06 | Iniziato | B. Riley Securities | Buy |
| 2023-01-30 | Iniziato | SVB Securities | Outperform |
| 2022-12-05 | Iniziato | Cowen | Outperform |
| 2022-11-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-02 | Iniziato | BofA Securities | Buy |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-12-10 | Ripresa | Raymond James | Mkt Perform |
| 2021-09-21 | Iniziato | Oppenheimer | Outperform |
| 2021-09-01 | Iniziato | SMBC Nikko | Outperform |
| 2021-05-18 | Iniziato | UBS | Buy |
| 2021-02-26 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-10 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-08-20 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-02-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-02-24 | Iniziato | Jefferies | Buy |
| 2020-02-19 | Iniziato | Stifel | Hold |
| 2020-01-27 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-09-26 | Iniziato | Wedbush | Neutral |
| 2019-09-13 | Iniziato | Nomura | Buy |
| 2019-08-09 | Iniziato | BTIG Research | Buy |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2018-11-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-11-12 | Iniziato | Janney | Buy |
| 2018-03-12 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-01-02 | Iniziato | Evercore ISI | Outperform |
| 2018-01-02 | Iniziato | Goldman | Neutral |
| 2018-01-02 | Iniziato | JP Morgan | Overweight |
| 2018-01-02 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Denali Therapeutics Inc Borsa (DNLI) Ultime notizie
Will Denali Therapeutics Inc. stock rally after Fed decisionsStop Loss & Capital Protection Trade Alerts - newser.com
Understanding Denali Therapeutics Inc.’s price movementMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
How to forecast Denali Therapeutics Inc. trends using time seriesWeekly Trend Summary & Advanced Swing Trade Entry Alerts - newser.com
Can Denali Therapeutics Inc. (4DN) stock resist broad market declinesMarket Weekly Review & Weekly Top Stock Performers List - newser.com
Tick level data insight on Denali Therapeutics Inc. volatilityTrend Reversal & Reliable Volume Spike Alerts - newser.com
Forecasting Denali Therapeutics Inc. price range with options data2025 Year in Review & Fast Entry High Yield Stock Tips - newser.com
What institutional flow reveals about Denali Therapeutics Inc.Quarterly Growth Report & Verified Swing Trading Watchlist - newser.com
Will Denali Therapeutics Inc. bounce back from current supportWeekly Trade Review & High Conviction Buy Zone Alerts - newser.com
Denali Therapeutics' (DNLI) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Is Denali Therapeutics Inc a good long term investmentFinancial Sector Performance & Start Small. End Wealthy. - earlytimes.in
What the Next Quarters Forecast Means for Beacon Trusteeship Limited InvestorsQuarterly Earnings Review & Free Tools to Find Winning Stocks - earlytimes.in
Denali Therapeutics Inc 4DN Stock Analysis and ForecastSector Performance Review & Get Free Expert Trading Recommendations - earlytimes.in
How to monitor Denali Therapeutics Inc. with trend dashboardsJuly 2025 Opening Moves & Consistent Profit Trade Alerts - newser.com
Regression analysis insights on Denali Therapeutics Inc. performanceBull Run & Consistent Return Strategy Ideas - newser.com
Should you hold or exit Denali Therapeutics Inc. nowJuly 2025 Institutional & Verified Swing Trading Watchlist - newser.com
Visual analytics tools that track Denali Therapeutics Inc. performanceTake Profit & Weekly Breakout Stock Alerts - newser.com
Is MPF Systems Limited a Smart Pick for Retirement PortfoliosStock Correlation Metrics & Build Wealth With Expert Timing Advice - earlytimes.in
Deutsche Bank sets $31 target for Denali Therapeutics stock - MSN
BofA Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $27 - 富途牛牛
Why Denali Therapeutics Inc. stock attracts global investorsPortfolio Risk Report & Free Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-03 02:14:22 - newser.com
Published on: 2025-10-03 01:11:36 - newser.com
Here's Why We're Not Too Worried About Denali Therapeutics' (NASDAQ:DNLI) Cash Burn Situation - 富途牛牛
Denali Therapeutics (NASDAQ:DNLI) Trading 7.4% HigherHere's What Happened - MarketBeat
What drives Denali Therapeutics Inc 4DN stock priceSector Rotation Strategies & Low Risk Trading Growth - earlytimes.in
Published on: 2025-09-30 04:04:18 - newser.com
Denali Therapeutics (DNLI): Evaluating Valuation Disconnect Despite Lack of Major News - Yahoo Finance
Published on: 2025-09-29 05:10:38 - newser.com
What drives Denali Therapeutics Inc stock priceSwing Trading Ideas & Low Risk Wealth Plans - earlytimes.in
What analysts say about Denali Therapeutics Inc stockGlobal Market Influence & Small Investment Capital Tips - earlytimes.in
Denali Therapeutics Inc Stock Analysis and ForecastSector Leadership Analysis & Free Get High Potential Alerts - earlytimes.in
Published on: 2025-09-27 18:12:42 - newser.com
Denali Therapeutics Inc Azioni (DNLI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Denali Therapeutics Inc Azioni (DNLI) insider trading
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):